Several ongoing trials are examining the agent in earlier settings (i.e., a phase III in mCRPC pre-docetaxel, and smaller studies in combination with radiation therapy or as neoadjuvant pre-surgery for localized disease).
Caretaking strategies that avoid violent punishment, but provide possibilities for a secure bonding, can ameliorate the mental health of children who experienced violence in earlier settings [ 8, 9].
In contrast to previous analyses of earlier mortality in this site (2), the onset of increasing mortality among younger adults is now clearly seen, as noted earlier in other settings such as the Agincourt HDSS (6).
In Bach's earlier settings of the mass he had treated "Qui tollis and "Qui sedes" as one movement, here he distinguished Jesus at the right hand of the father by dance-like music.
All cases expressing cyclin E, p21 and p53 were considered positive, this in accordance with earlier settings of (Michalides et al, 1996; Van Diest et al, 1997; Barbareschi et al, 2000).
Paclitaxel and docetaxel are standard therapies in advanced non small-cell lunon small-celllungand are incancerNSCLCused in eandier treareent settincreasingly
Girls and boys will perform similarly in earlier education settings, but once entering college, girls are less likely to choose a STEM field as their area of specialization.
In essence, these New England fishermen were interacting with the marine environment in ways that were not only evident in earlier historical settings, but have also become very familiar since the 1850s: faced with environmental changes, which their activity had precipitated, they extended the spatial scope, and enhanced the intensity, of their fishing effort.
In addition to the PREVAIL trial in men with chemotherapy-naïve CRPC, enzalutamide will continue to be investigated in earlier disease settings.
Research is ongoing to identify short-term markers of the long-term clinical benefits of sipuleucel-T treatment, to investigate its use in earlier disease settings, and in combination with other therapies.
These trials are addressing several aspects of sipuleucel-T therapy, such as use in earlier treatment settings (neoadjuvant, hormone sensitive, and non-metastatic) and the combination of sipuleucel-T with other agents (chemotherapy, radiotherapy, ADT, abiraterone acetate, and immunotherapeutics).
